Diagnostic and Prognostic Role of 18F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept

Francesco Fiz; Gianluca Bottoni; Giorgio Treglia; Pierpaolo Trimboli; Arnoldo Piccardo

doi:10.3390/jcm11133589

Diagnostic and Prognostic Role of ¹⁸F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept

J Clin Med. 2022 Jun 22;11(13):3589. doi: 10.3390/jcm11133589.

Authors

Francesco Fiz¹, Gianluca Bottoni¹, Giorgio Treglia^{2

3

4}, Pierpaolo Trimboli^{4

5}, Arnoldo Piccardo¹

Affiliations

¹ Nuclear Medicine Department, E.O. "Ospedali Galliera", 16128 Genoa, Italy.
² Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.
³ Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
⁴ Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
⁵ Clinic of Endocrinology and Diabetology, Lugano and Mendrisio Regional Hospital, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.

Abstract

Since the discovery of the role of female hormones in breast cancer (BC) pathophysiology, in vivo detection of oestrogen receptor (ER) distribution has been one of the major goals of nuclear medicine and molecular imaging [...].

Publication types

Editorial